The information in this preliminary pricing supplement is not complete and may be changed. A registration statement relating to these securities has been filed with the Securities and Exchange Commission. This preliminary pricing supplement and the accompanying product supplement, underlying supplement, prospectus supplement and prospectus are not an offer to sell... (continue reading...)
Filed by Pulmatrix, Inc.
Pursuant to Rule 425 under the Securities Act of 1933
and deemed filed pursuant to Rule 14a-12
of the Securities Exchange Act of 1934
Subject Companies: Pulmatrix, Inc. and Eos SENOLYTIX, Inc.
Commission File No. 333-297342
MitoXcel™ Geropeptide PTC-2105 Attenuates Terminal Lean-Mass Decline and Semaglutide-Associated Lean-Mass Loss in Aged Mice
Daniel Jasinski, Ph.D., Meena Balakrishnan, Kyra Courtney, Samantha Moreno,... (continue reading...)
October 8, 2026
Registration Statement Nos. 333-293684 and 333-293684-01; Rule 424(b)(2)
JPMorgan Chase Financial Company LLCStructured Investments
$1,744,000
Capped... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the month of: October 2026
Commission file number: 001-41557
CLEARMIND MEDICINE INC.
(Translation of registrant’s name into English)
101 – 1220 West 6th Avenue
Vancouver, British Columbia
(Address of principal executive offices)
More SEC Filings
View Older Stories-
Form 6-K Tencent Music Entertainm For: Oct 13
-
Form 8-K TUTOR PERINI CORP For: Oct 07
-
Form 8-K Braemar Hotels & Resorts For: Oct 13
-
Form DEFA14A AmpliTech Group, Inc.
-
Form 424B2 CITIGROUP INC
-
Form 8-K Hyperscale Data, Inc. For: Oct 13
-
Form 13F-HR CALEDONIA INVESTMENTS For: Sep 30
-
Form 13F-HR BALDWIN WEALTH PARTNERS For: Sep 30
-
Form 6-K NOVO NORDISK A S For: Oct 12
-
Form 6-K STANDARD LITHIUM LTD. For: Oct 13
-
Form 8-K UNITEDHEALTH GROUP INC For: Oct 13
-
Form 424B2 ROYAL BANK OF CANADA
-
Form 424B2 CITIGROUP INC
-
Form 13F-NT Pendal Group Ltd For: Sep 30
-
Form SCHEDULE 13D/A CytoMed Therapeutics Filed by: Choo Chee Kong
-
Form 424B2 CITIGROUP INC
-
Form 424B2 HSBC USA INC /MD/
-
Form 6-K HSBC HOLDINGS PLC For: Oct 13
-
Form 6-K Gix Internet Ltd. For: Oct 13
-
Form 424B2 CITIGROUP INC
-
Form 3 Abits Group Inc For: Aug 05 Filed by: Hancox Andrew
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 CITIGROUP INC
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 CITIGROUP INC
-
Form 6-K Hafnia Ltd For: Oct 12
-
Form 6-K Ohmyhome Ltd For: Oct 13
-
Form 8-K UNITY BANCORP INC /NJ/ For: Oct 13
-
Form 6-K KT CORP For: Oct 13
-
Form 13F-NT JOHCM (USA) Inc For: Sep 30
-
Form 6-K Li Auto Inc. For: Oct 13
-
Form 8-K Enovix Corp For: Oct 12
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 6-K AEGON LTD. For: Oct 13
-
Form 424B2 CITIGROUP INC
-
Form 8-K Co-Diagnostics, Inc. For: Oct 09
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 144 Kinetik Holdings Inc. Filed by: ISQ Global Fund II GP LLC
-
Form 6-K ING GROEP NV For: Oct 13
-
Form 6-K Basel Medical Group Ltd For: Oct 13
-
Form 6-K COCA-COLA EUROPACIFIC For: Oct 13
-
Form 6-K EQUINOR ASA For: Oct 13
-
Form 8-K TTM TECHNOLOGIES INC For: Oct 12
-
Form 8-K Bausch & Lomb Corp For: Oct 11
-
Form 424B2 TORONTO DOMINION BANK
-
Form 424B2 TORONTO DOMINION BANK
-
Form 10-Q DOMINOS PIZZA INC For: Sep 06
-
Form PRER14A bioAffinity Technologies
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 6-K KE Holdings Inc. For: Oct 13


